Catalyst Pharmaceuticals Inc (CPRX) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Catalyst Pharmaceuticals Inc   (NASDAQ: CPRX)
 

Catalyst Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPRX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 5.63 % 12.22 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -2.11 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 11.65 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 1.35 % 2.69 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 37.68 % 7.41 % 8.65 % 10.59 %


CPRX's Growth Comparisons in I. Quarter 2026




Catalyst Pharmaceuticals Inc 's Revenue slowed to the 5.63% year on year, improvement in the first quarter 2026 to 149 millions, underperforming the 12.22% rise in the Major Pharmaceutical Preparations industry and 8.91% Revenue growth in the Healthcare sector. Comparing the first quarter, sales Catalyst Pharmaceuticals Inc was trailing overall market not just Major Pharmaceutical Preparations industry.

Top-line fell by -2.11% from the fourth quarter. Average annual sales growth for Catalyst Pharmaceuticals Inc is 37.68%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the first quarter 2026 financial results.

CPRX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
FIRDAPSE
18.07 %
-
FYCOMPA
-61.35 %
-
AGAMREE
66.56 %
-
Product revenue net
5.62 %
-
Total
5.63 %
-


Growth Rates of CPRX's Income in the first quarter 2026


CPRX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 15.57 % -8.88 % 4.62 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) 18.41 % -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) 15.68 % 30.63 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) 3.83 % -2.27 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change 44.23 % 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 12.33 % -34.9 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 20.94 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 12.15 % 6.3 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 3.26 % -10.02 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 23.37 % -0.55 % 0.17 % -28.52 %

CPRX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 12.33 % -35.09 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) 20.94 % 2.87 % -0.77 % 27.07 %
Y / Y Net Income Change (Q1 TTM) 12.15 % 5.21 % 15.51 % 57.33 %
Sequential Net Income Change (Q1 TTM) 3.26 % -10.17 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 23.37 % 14.55 % 9.21 % 22.96 %

CPRX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 10.64 % -40.27 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 21.3 % -7.72 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 9.19 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 2.84 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 19.44 % -10.78 % 0.17 % -28.52 %



CPRX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 11.11 % -40.45 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) 22.51 % -2.53 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 2.96 % - - 4.93 %
EPS Net 5 Year Avg. Change 18.8 % 14.55 % 9.21 % 22.96 %



Catalyst Pharmaceuticals Inc bucks the industry trend and shows 11.11% year on year EPS increase in the first quarter to $0.50, while Major Pharmaceutical Preparations industry declined by -40.45%, Healthcare sector dropped -26.26%. Slow first quarter 2026 income per share, in Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in the Catalyst Pharmaceuticals Inc results which underperformed overall market.

The company's sequential bottom-line increase was 22.51% from the fourth quarter. Average annual income per share rise for Catalyst Pharmaceuticals Inc is 18.8%, while S & P 500's average yearly income per share growth is 22.96% over the five years, including only Businesses with the first quarter 2026 earnings results.

CPRX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -0.8 % 25.53 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) 32.77 % -42.37 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) -22.21 % 11.91 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) -0.23 % 3.24 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 35.89 % 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) -26.01 % - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) 142.17 % - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) -35.17 % - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 36.31 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) - 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) -15.63 % -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -76.19 % 16.65 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 46.55 % 2.92 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 8.82 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.